The median PFS was about 9
The median PFS was about 9.3 months in and 8.7 months in populations. inconclusive for the same therapy. In comparison, panitumumab results Buserelin Acetate in better progression-free survival which is…
Yuan Con, Wang JY, Yuan F, Xie KL, Yu YH, Wang GL
Yuan Con, Wang JY, Yuan F, Xie KL, Yu YH, Wang GL. MMP-9 was indicated mainly in DRG neurons co-expressing mu opioid receptors (MOR), and elicited interleukin-1 (IL-1) cleavage in…